Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 9 Lung Neoplasms 9 Breast Neoplasms 8 Colorectal Neoplasms 6 Hematopoietic and Lymphatic System Neoplasm 4 Hematologic Neoplasms 2 Fatigue 2 Chronic Pain 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Malignant Solid Neoplasm 2 Venous Thrombosis 1 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Syndrome 1 Sunburn 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Sarcoma 1 Pulmonary Embolism 1 Psoriasis 1 Overweight 1 Ovarian Neoplasms 1 Obesity-Related Malignant Neoplasm 1 Obesity 1 Neoplastic Syndromes, Hereditary 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 28 fludarabine 19 Rituximab 17 obinutuzumab 12 venetoclax 10 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 ibrutinib 5 fludarabine phosphate 5 Biopsy 5 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Educational Status × Clear all

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡